Tech Company Financing Transactions
32 Biosciences Funding Round
32 Biosciences closed a $6 million funding round on 6/11/2025. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/11/2025
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the continued development of its lead assets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3333 Green Bay Rd. Innovation and Research Park 210
North Chicago, IL 60064
USA
North Chicago, IL 60064
USA
Phone
Website
Email Address
Overview
32 Biosciences was born out of a groundbreaking vision to redefine healthcare through the power of the gut microbiome. Rooted in over two decades of pioneering research at The University of Chicago and the University of Wisconsin-Madison, our journey began with the collaboration of three world-renowned scientific founders--Dr. John Alverdy, Dr. Gene Chang, and Dr. Joseph Pierre. Together, their insights into the gut microbial organ revealed its pivotal role in human health, inspiring us to develop innovative solutions that address unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Farmakis
Browse more venture capital transactions:
Prev: 6/11/2025: Hyperion venture capital transaction
Next: 6/11/2025: Tracksuit venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs